Index of reports
> Cases with Respiratory Failure (3)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Erythrocin (Erythromycin) where reactions include respiratory failure. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Erythrocin side effects in female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-02-08
Patient: female, weighing 25.7 kg (56.5 pounds)
Reactions: Pancreatitis Acute, Respiratory Failure, Disseminated Intravascular Coagulation, Acidosis, Cardiac Arrest, Blood Pressure Decreased, Anuria
Adverse event resulted in: death
Drug(s) suspected as cause:
Amphotericin B
Dosage: see image
Indication: Pneumonia
Start date: 2010-03-01
End date: 2010-04-06
Amphotericin B
Dosage: see image
Indication: Pneumonia
Start date: 2010-04-07
End date: 2010-04-12
Erythrocin
Dosage: ([2 in 1 day, after breakfast and supper (200 mg, 2 in 1 day, after breakfast and supper)] oral)
Administration route: Oral
Indication: Primary Ciliary Dyskinesia
Start date: 2005-01-01
End date: 2010-04-12
Other drugs received by patient: Midazolam; Clobazam; Tazobactam; Gabapentin; Natural Aluminum Silicate; Monoammonium; Valproate Sodium; Carbocisteine Lysine; Budesonide; Teicoplanin; Clonidine HCL; Antibiotics-Resistant Lactic Acid Bacteriae; Albumin Tannate; Minocycline Hydrochloride; Phenobarbital TAB; Ambroxol Hydrochloride; Doripenem Monohydrate; Ethyl Loflazepate; Pranlukast; Sodium Bromide
Possible Erythrocin side effects in female
Reported by a health professional (non-physician/pharmacist) from Japan on 2011-12-23
Patient: female, weighing 25.7 kg (56.5 pounds)
Reactions: Pancreatitis Acute, Vomiting, Disseminated Intravascular Coagulation, Acidosis, Heart Rate Decreased, Respiratory Failure, Abdominal Distension, Cardiac Arrest, Blood Pressure Decreased, Anuria
Adverse event resulted in: death
Drug(s) suspected as cause:
Amphotericin B
Dosage: (100 mg intravenous (not otherwise specified) (100 mg qd intravenous (not otherwise specified)
Indication: Pneumonia
Start date: 2010-03-01
Amphotericin B
Dosage: (100 mg intravenous (not otherwise specified) (100 mg qd intravenous (not otherwise specified)
Indication: Pneumonia
Start date: 2010-04-07
End date: 2010-04-12
Erythrocin
Dosage: (200 mg bid oral)
Administration route: Oral
Indication: Primary Ciliary Dyskinesia
End date: 2010-04-12
Other drugs received by patient: Carbocisteine Lysine; Ambroxol Hydrochloride; Monoammonium Glycyrrhizinate; Gabapentin; Doripenem Monohydrate; Teicoplanin; Clobazam; Ethyl Loflazepate; Albumin Tannate; Antibiotics-Resistant Lactic Acid Bacteriae; Valproate Sodium; Minocycline Hydrochloride; Budesonide; Tazobactam; Phenobarbital TAB; Pranlukast; Sodium Bromide; Clonidine Hydrochloride; Natural Aluminum Silicate
Possible Erythrocin side effects in female
Reported by a health professional (non-physician/pharmacist) from Japan on 2011-10-13
Patient: female, weighing 27.5 kg (60.5 pounds)
Reactions: Arrhythmia, Uterine Cancer, Blood Potassium Decreased, Respiratory Failure, Ventricular Tachycardia, Chest Pain, COR Pulmonale, Respiratory Arrest, Depressed Level of Consciousness, Electrolyte Imbalance, Obstructive Airways Disorder
Adverse event resulted in: death
Drug(s) suspected as cause:
Clarithromycin
Dosage: (200 mg (200 mg, 1 in 1 d) oral), (800 mg, 800 g (400 mg , 2 in 1 d), oral
Administration route: Oral
Indication: Bronchiolitis
Start date: 2006-06-30
End date: 2006-09-18
Clarithromycin
Dosage: (200 mg (200 mg, 1 in 1 d) oral), (800 mg, 800 g (400 mg , 2 in 1 d), oral
Administration route: Oral
Indication: Bronchiolitis
Start date: 2006-09-19
End date: 2006-10-16
Rythmodan / 00271801 / (Rythmodan) (Not Specified)
Dosage: (300 mg, 300 mg (100 mg, 3 in 1 d) oral)
Administration route: Oral
Indication: Supraventricular Tachycardia
End date: 2006-10-16
Acardi (Acardi) (Not Specified)
Dosage: (5 mg, 5 mg ( 2.5 mg, 2 in 1 d) oral)
Administration route: Oral
Indication: Cardiac Failure Chronic
End date: 2006-10-16
Erythrocin
Dosage: (600 mg, 600 mg (200 mg, 3 in 1 d), oral
Administration route: Oral
Indication: Bronchiolitis
Start date: 1992-01-01
End date: 2006-06-29
Other drugs received by patient: Zolpidem Tartrate; Rabeprazole Sodium; Furosemide; Isosorbide Dinitrate; Radiotherapy; Theophylline; Ursodiol; Tiotropium Bromid Monohydrate
|